scispace - formally typeset
I

Ichiro Ieiri

Researcher at Kyushu University

Publications -  194
Citations -  8859

Ichiro Ieiri is an academic researcher from Kyushu University. The author has contributed to research in topics: Population & Pharmacokinetics. The author has an hindex of 48, co-authored 173 publications receiving 8175 citations. Previous affiliations of Ichiro Ieiri include University of Tokyo & Tottori University.

Papers
More filters
Journal Article

Expression of P-glycoprotein in human placenta : relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene

TL;DR: Although it remains to be determined whether these SNPs influence the pharmacokinetic and dynamic properties of clinically useful drugs that are substrates of PGP, the polymorphism of the MDR-1 gene presented here may provide useful information in in vivo study of these issues.
Journal ArticleDOI

Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics.

TL;DR: The objective was to quantitate the contribution of the genetic polymorphisms of the genes for 2 human organic anion transporters—organic anion transporting polypeptide C (OATP‐C) and organic anions transporter 3 ( OAT3)—to the pharmacokinetics of pravastatin.
Journal ArticleDOI

Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans

TL;DR: Japanese are more susceptible to inhibition of NPT production by S-warfarin than the other two populations, and VKORC1 and CYP2C9 polymorphisms contribute to inter-population difference in warfarin doses among the three populations, but their contribution to intra-population variability may differ within each population.
Journal ArticleDOI

Functional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placenta.

TL;DR: The results suggest that 1) the predominant allelic expression pattern of BCRP in placental samples is biallelic, and 2) the mutation C421A is not a genetic variant acting in cis, but is considered to influence the translation efficiency.